(Q38539190)

3 September 2017

1 reference

title

Defeating AIDS--advancing global health (English)

1 reference

3 September 2017

0 references

1

Peter Piot

Peter

Piot

1 reference

3 September 2017

2

Salim S. Abdool Karim

author given names

Salim S. Abdool

author last names

Karim

0 references

Helena Legido-Quigley

4

object named as

Helena Legido-Quigley

author given names

Helena

author last names

Legido-Quigley

1 reference

3 September 2017

7

Stephen Resch

Stephen

Resch

1 reference

3 September 2017

Theresa Ryckman

8

Theresa

Ryckman

0 references

10

Mark Dybul

Mark

Dybul

1 reference

3 September 2017

12

Charlotte Watts

Charlotte

Watts

1 reference

3 September 2017

Robert Hecht

3

1 reference

3 September 2017

Kent Buse

5

1 reference

3 September 2017

John Stover

6

1 reference

3 September 2017

Sigrun Møgedal

9

1 reference

3 September 2017

Eric Goosby

11

1 reference

3 September 2017

Nduku Kilonzo

13

1 reference

3 September 2017

Joanne McManus

14

1 reference

3 September 2017

Michel Sidibé

15

1 reference

3 September 2017

UNAIDS–Lancet Commission

16

1 reference

3 September 2017

language of work or name

English

0 references

publication date

24 June 2015

1 reference

3 September 2017

1 reference

3 September 2017

386

1 reference

3 September 2017

9989

1 reference

3 September 2017

171-218

1 reference

Global health 2035: a world converging within a generation

3 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The political origins of health inequity: Prospects for change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Seroprevalence of HIV infection in rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Intimate partner violence against women in eastern Uganda: implications for HIV prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Increased risk of HIV in women experiencing physical partner violence in Nairobi, Kenya.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Rape perpetration by young, rural South African men: Prevalence, patterns and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

HIV-positive women report more lifetime partner violence: findings from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Global epidemiology of HIV among female sex workers: influence of structural determinants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Elevated risk for HIV infection among men who have sex with men in low- and middle-income countries 2000-2006: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Epidemiology of HIV in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Trends in diagnoses of HIV infection in the United States, 2002-2011.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

HIV risk among MSM in Senegal: a qualitative rapid assessment of the impact of enforcing laws that criminalize same sex practices

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Prevention of HIV-1 infection with early antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The cost and cost-effectiveness of gender-responsive interventions for HIV: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Impact of stepping stones on incidence of HIV and HSV-2 and sexual behaviour in rural South Africa: cluster randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Effectiveness of an integrated intimate partner violence and HIV prevention intervention in Rakai, Uganda: analysis of an intervention in an existing cluster randomised cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Effect of a structural intervention for the prevention of intimate-partner violence and HIV in rural South Africa: a cluster randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The impact of SASA!, a community mobilization intervention, on reported HIV-related risk behaviours and relationship dynamics in Kampala, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Effectiveness of needle-exchange programmes for prevention of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

How AIDS invented global health

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

A global framework convention on health: would it help developing countries to fulfil their duties on the right to health? A South African perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Towards a framework convention on global health

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Towards an improved investment approach for an effective response to HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Malaria resurgence: a systematic review and assessment of its causes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

China's syphilis epidemic: epidemiology, proximate determinants of spread, and control responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe, 2000-6: implications for a European public health strategy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Behavioral, biological, and demographic risk and protective factors for new HIV infections among youth in Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The burden of HIV: insights from the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The end of AIDS: possibility or pipe dream? A tale of transitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Primary HIV Infection, phylogenetics, and antiretroviral prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Community mobilisation and empowerment interventions as part of HIV prevention for female sex workers in Southern India: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Large disparities in HIV treatment cascades between eight European and high-income countries - analysis of break points

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Demedicalizing AIDS prevention and treatment in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Stigma impedes AIDS prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Provider-initiated HIV testing and counseling in low- and middle-income countries: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Two and a half years of routine HIV testing in Botswana

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

High acceptance of home-based HIV counseling and testing in an urban community setting in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The effects of home-based HIV counseling and testing on HIV/AIDS stigma among individuals and community leaders in western Kenya: evidence from a cluster-randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Home-based HIV testing and counseling in rural and urban Kenyan communities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Uptake of community-based HIV testing during a multi-disease health campaign in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Structural approaches to HIV prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The implications of policy changes on the uptake of a PMTCT programme in rural Malawi: first three years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Quality of antenatal and delivery care before and after the implementation of a prevention of mother-to-child HIV transmission programme in Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Profile: France's ANRS turns 25.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

UK investments in global infectious disease research 1997-2010: a case study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

A call to action for comprehensive HIV services for men who have sex with men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Time to act: a call for comprehensive responses to HIV in people who use drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Assessing household wealth in health studies in developing countries: a comparison of participatory wealth ranking and survey techniques from rural South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Limitations of the randomized controlled trial in evaluating population-based health interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Behavioral science at the crossroads in public health: extending horizons, envisioning the future

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Evidence-based public health: moving beyond randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Realist review--a new method of systematic review designed for complex policy interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Transforming social structures and environments to help in HIV prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Alternatives to randomisation in the evaluation of public-health interventions: statistical analysis and causal inference

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Health in the sustainable development goals: ready for a paradigm shift?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Addressing the interface of the political and commercial determinants of health

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Explorations on people centredness in health systems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Engaging citizens: lessons from building Brazil's national health system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

In a study of a population cohort in South Africa, HIV patients on antiretrovirals had nearly full recovery of employment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

When to start antiretroviral therapy in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Reduced premature mortality in Rwanda: lessons from success

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Assessing cost and technical efficiency of HIV prevention interventions in sub-Saharan Africa: the ORPHEA study design and methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The costs of scaling up HIV prevention for high risk groups: lessons learned from the Avahan Programme in India

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

The government of Kenya's cash transfer program reduces the risk of sexual debut among young people age 15-25.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

Child-focused state cash transfers and adolescent risk of HIV infection in South Africa: a propensity-score-matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2815%2960658-4

7 January 2021

10.1016/S0140-6736(15)60658-4

Identifiers

DOI

1 reference

3 September 2017

1 reference